NO880719L - Polypeptid, dna og anvendelse derav. - Google Patents
Polypeptid, dna og anvendelse derav.Info
- Publication number
- NO880719L NO880719L NO88880719A NO880719A NO880719L NO 880719 L NO880719 L NO 880719L NO 88880719 A NO88880719 A NO 88880719A NO 880719 A NO880719 A NO 880719A NO 880719 L NO880719 L NO 880719L
- Authority
- NO
- Norway
- Prior art keywords
- activity
- mutein
- fibroblast growth
- polypeptid
- dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4221887 | 1987-02-24 | ||
| JP4344487 | 1987-02-25 | ||
| JP8197787 | 1987-04-02 | ||
| JP14751187 | 1987-06-12 | ||
| JP20151087 | 1987-08-11 | ||
| JP29028387 | 1987-11-17 | ||
| JP63016260A JP2526965B2 (ja) | 1987-02-24 | 1988-01-26 | ムテイン，ｄｎａおよびその用途 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO880719D0 NO880719D0 (no) | 1988-02-18 |
| NO880719L true NO880719L (no) | 1988-08-25 |
| NO180305B NO180305B (no) | 1996-12-16 |
| NO180305C NO180305C (no) | 1997-03-26 |
Family
ID=27563743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO880719A NO180305C (no) | 1987-02-24 | 1988-02-18 | Rekombinant DNA som koder for et mutein av basisk fibroblastvekstfaktor, transformant som kan produsere dette og fremgangsmåte for fremstilling derav |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0281822B1 (no) |
| JP (1) | JP2526965B2 (no) |
| KR (1) | KR960013574B1 (no) |
| CN (1) | CN1031893C (no) |
| AT (1) | ATE108829T1 (no) |
| AU (1) | AU613564B2 (no) |
| CS (1) | CS407691A3 (no) |
| DE (1) | DE3850690T2 (no) |
| DK (1) | DK173269B1 (no) |
| ES (1) | ES2056842T3 (no) |
| FI (1) | FI96316C (no) |
| IE (1) | IE64299B1 (no) |
| IL (1) | IL85473A (no) |
| NO (1) | NO180305C (no) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5852177A (en) * | 1987-02-24 | 1998-12-22 | Takeda Chemical Industries, Ltd. | Basic fibroblast growth factor (bFGF) muteins |
| AU611614B2 (en) * | 1987-06-18 | 1991-06-13 | Monash University | Growth factors |
| JPH03500529A (ja) * | 1987-06-18 | 1991-02-07 | モナシュ ユニバーシティ | 増殖因子 |
| GB8821795D0 (en) * | 1988-09-16 | 1988-10-19 | Erba Carlo Spa | New derivatives of human/bovine basic fibroplast growth factor |
| US5352589A (en) * | 1988-09-16 | 1994-10-04 | Farmitalia Carlo Erba S.R.L. | Deletion mutant of basic fibroblast growth factor and production thereof |
| US5120715A (en) * | 1988-12-12 | 1992-06-09 | Takeda Chemical Industries, Ltd. | Method for purifying fibroblast growth factor protein |
| EP0394951A1 (en) * | 1989-04-26 | 1990-10-31 | Takeda Chemical Industries, Ltd. | Glycosylated bFGF and production thereof |
| US5464943A (en) * | 1989-04-26 | 1995-11-07 | Takeda Chemical Industries, Ltd. | DNA encoding glycosylated FGF and production thereof |
| CA2020654A1 (en) * | 1989-07-07 | 1991-01-08 | Yohko Akiyama | Stabilized fgf composition and production thereof |
| AU7162791A (en) * | 1989-12-27 | 1991-07-24 | Miroslav Radman | Novel system for isolating and producing new genes, gene products and dna sequences |
| EP0507948A1 (en) | 1989-12-28 | 1992-10-14 | Takeda Chemical Industries, Ltd. | Monoclonal antibody, hybridomas, their production and use |
| JPH047617A (ja) * | 1990-04-26 | 1992-01-13 | Canon Inc | 電子機器 |
| US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
| US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
| CA2056142A1 (en) | 1990-11-27 | 1992-05-28 | Hirotomo Masuya | Pyridopyridazine compounds and their use |
| EP0499242B1 (en) * | 1991-02-15 | 1996-06-26 | Takeda Chemical Industries, Ltd. | Stimulation of endosteal bone formation with a cell growth factor |
| ES2087323T3 (es) * | 1991-02-19 | 1996-07-16 | Takeda Chemical Industries Ltd | Metodo para producir peptidos exentos de cisteina. |
| US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
| TW209174B (no) | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
| JP3303211B2 (ja) * | 1991-04-26 | 2002-07-15 | 武田薬品工業株式会社 | ｂＦＧＦムテインおよびその製造法 |
| US5461029A (en) * | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
| US6805865B1 (en) * | 1993-05-27 | 2004-10-19 | Entremed, Inc. | Compositions and methods for treating cancer and hyperproliferative disorders |
| JPH07114789B2 (ja) * | 1993-08-26 | 1995-12-13 | 工業技術院長 | 上肢動作補助機構 |
| CA2172137C (en) * | 1993-09-24 | 1999-12-14 | Andrew Peter Seddon | Surface loop structural analogues of fibroblast growth factors |
| JP2562413B2 (ja) * | 1993-11-04 | 1996-12-11 | 株式会社東京機械製作所 | 版胴における刷版装着装置 |
| IT1269321B (it) * | 1994-04-15 | 1997-03-26 | Eniricerche Spa | Mutanti stabili della d-n- -carbamilasi |
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
| AU773002B2 (en) | 1999-04-02 | 2004-05-13 | Kci Licensing, Inc. | Vacuum assisted closure system with provision for introduction of agent |
| CN1671836B (zh) | 2002-06-18 | 2012-02-08 | 卫材R&D管理有限公司 | 用于基因治疗的原代培养脂肪细胞 |
| US8399440B2 (en) | 2006-03-20 | 2013-03-19 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
| CN102690782A (zh) * | 2012-06-14 | 2012-09-26 | 安徽农业大学 | 一种成纤维细胞培养液 |
| KR101610861B1 (ko) * | 2014-07-28 | 2016-04-11 | (주)케어젠 | 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도 |
| CN105924532A (zh) * | 2016-06-08 | 2016-09-07 | 盘古基因生物工程(南京)股份有限公司 | 一种可溶性碱性成纤维细胞生长因子融合蛋白表达载体及其应用 |
| CN121518527A (zh) * | 2026-01-15 | 2026-02-13 | 泰州博莱得利生物科技有限公司 | 一种重组猫碱性成纤维细胞生长因子溶液的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI82266C (fi) * | 1982-10-19 | 1991-02-11 | Cetus Corp | Foerfarande foer framstaellning av il-2 -mutein. |
| US4956455A (en) * | 1984-03-05 | 1990-09-11 | The Salk Institute For Biological Studies | Bovine fibroblast growth factor |
| EP0248819B2 (en) * | 1985-09-12 | 2000-08-30 | Scios Inc. | Recombinant fibroblast growth factors |
| AU629176B2 (en) * | 1987-07-07 | 1992-10-01 | Scios Nova Inc. | Recombinant fibroblast growth factors |
| JPH02504468A (ja) * | 1987-11-24 | 1990-12-20 | アムジエン・インコーポレーテツド | 繊維芽細胞成長因子のアナログ |
-
1988
- 1988-01-26 JP JP63016260A patent/JP2526965B2/ja not_active Expired - Lifetime
- 1988-02-18 NO NO880719A patent/NO180305C/no not_active IP Right Cessation
- 1988-02-19 IL IL85473A patent/IL85473A/xx not_active IP Right Cessation
- 1988-02-20 DE DE3850690T patent/DE3850690T2/de not_active Expired - Lifetime
- 1988-02-20 AT AT88102491T patent/ATE108829T1/de not_active IP Right Cessation
- 1988-02-20 ES ES88102491T patent/ES2056842T3/es not_active Expired - Lifetime
- 1988-02-20 EP EP88102491A patent/EP0281822B1/en not_active Expired - Lifetime
- 1988-02-23 IE IE48288A patent/IE64299B1/en not_active IP Right Cessation
- 1988-02-23 AU AU12085/88A patent/AU613564B2/en not_active Expired
- 1988-02-23 FI FI880845A patent/FI96316C/fi active IP Right Grant
- 1988-02-23 DK DK198800926A patent/DK173269B1/da not_active IP Right Cessation
- 1988-02-24 CN CN88100913A patent/CN1031893C/zh not_active Expired - Lifetime
- 1988-02-24 KR KR88001949A patent/KR960013574B1/ko not_active Expired - Fee Related
-
1991
- 1991-12-27 CS CS914076A patent/CS407691A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1208588A (en) | 1988-08-25 |
| ES2056842T3 (es) | 1994-10-16 |
| CN88100913A (zh) | 1988-09-07 |
| NO180305C (no) | 1997-03-26 |
| AU613564B2 (en) | 1991-08-01 |
| DE3850690D1 (de) | 1994-08-25 |
| KR880010130A (ko) | 1988-10-07 |
| EP0281822A2 (en) | 1988-09-14 |
| FI880845A0 (fi) | 1988-02-23 |
| IL85473A (en) | 1997-03-18 |
| EP0281822B1 (en) | 1994-07-20 |
| CS407691A3 (en) | 1992-06-17 |
| FI96316B (fi) | 1996-02-29 |
| FI880845L (fi) | 1988-08-25 |
| DK92688D0 (da) | 1988-02-23 |
| ATE108829T1 (de) | 1994-08-15 |
| IE880482L (en) | 1988-08-24 |
| JP2526965B2 (ja) | 1996-08-21 |
| DK92688A (da) | 1988-08-25 |
| EP0281822A3 (en) | 1990-03-21 |
| IE64299B1 (en) | 1995-07-26 |
| JPH02193A (ja) | 1990-01-05 |
| DK173269B1 (da) | 2000-05-29 |
| KR960013574B1 (en) | 1996-10-09 |
| DE3850690T2 (de) | 1995-01-05 |
| NO180305B (no) | 1996-12-16 |
| CN1031893C (zh) | 1996-05-29 |
| NO880719D0 (no) | 1988-02-18 |
| FI96316C (fi) | 1996-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK92688A (da) | Polypeptid, dna og anvendelse deraf | |
| DK357386D0 (da) | Saarhelende midler | |
| GEP20033145B (en) | Stem Cell Factor | |
| DE69001839D1 (de) | 1-hydroxyvitamin d2-epimer und dessen derivate. | |
| FI885807L (fi) | Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen | |
| ATE97813T1 (de) | Mittel zur kontrolle von thrombenbildungen. | |
| ES2057544T3 (es) | Composiciones estabilizadas a base de fgf. | |
| DE69530303D1 (de) | Neue verwendung von prostaglandinen | |
| ATE189393T1 (de) | Therapeutisches agens zur wundbehandlung | |
| ATE80616T1 (de) | Prostaglandin e1-derivate und ihre therapeutische anwendung. | |
| DE3881615D1 (de) | Wasserunloesliche cytokine. | |
| DE69018357D1 (de) | Mutein von HST-1 und seine Herstellung. | |
| ES2094757T3 (es) | Un factor megacariocitopoyetico. | |
| DE68920900D1 (de) | Prourokinasederivate mit niedrigem Molekulargewicht und sie enthaltende pharmazeutische Zusammensetzungen. | |
| NO169127C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt pepti | |
| IT8819559A0 (it) | Impiego terapeutico dell'acido uridinfosfoglucuronico (udpg_a)come attivatore della glucuronconiugazione del trattamento di epatopie ed itteri. | |
| SE8401907L (sv) | Nya fenoxipropanolaminsalter och farmaceutiska beredningar derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |